Cambridge Investment Research Advisors
ETRM

Cambridge Investment Research Advisors’s EnteroMedics Inc. ETRM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-15
Closed -$2K – 1698
2015
Q4 		$2K Hold
15
– – ﹤0.01% 1576
2015
Q3 		$4K Hold
15
– – ﹤0.01% 1434
2015
Q2 		$10K Hold
15
– – ﹤0.01% 1436
2015
Q1 		$14K Hold
15
– – ﹤0.01% 1401
2014
Q4 		$22K Hold
15
– – ﹤0.01% 1348
2014
Q3 		$19K Buy
15
+2
+15% +$2.93K ﹤0.01% 1450
2014
Q2 		$22K Hold
13
– – ﹤0.01% 1327
2014
Q1 		$25K Hold
13
– – ﹤0.01% 1281
2013
Q4 		$28K Buy
+13
New +$21K ﹤0.01% 1218

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Cambridge Investment Research Advisors's ETRM Position: Q1 2016 in Review

Cambridge Investment Research Advisors sold out of EnteroMedics Inc. (ETRM) in Q1 2016, closing a stake of 15 shares — an estimated $2K sold.

Cambridge Investment Research Advisors first reported a position in ETRM in Q4 2013 and held it in 9 quarters. The position peaked at $28K in Q4 2013. 26 funds tracked by Wall St. Rank hold ETRM as of Q1 2016.

  • Cambridge Investment Research Advisors reported no remaining EnteroMedics Inc. position as of Q1 2016 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15 EnteroMedics Inc. shares in Q1 2016, an estimated $2K.
  • Cambridge Investment Research Advisors first reported a position in EnteroMedics Inc. in Q4 2013 and held it in 9 quarters.
  • Cambridge Investment Research Advisors's EnteroMedics Inc. position peaked at $28K in Q4 2013.
  • 26 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2016.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.